Harmony Biosciences Holdings (HRMY) — Free Cash Flow Generation Index
Harmony Biosciences Holdings (HRMY) has a Free Cash Flow Generation Index of 1.00x as of June 2026. Free cash flow of $92.43 Million represents 1% of operating cash flow ($92.43 Million). Explore HRMY capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Harmony Biosciences Holdings Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for Harmony Biosciences Holdings across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Harmony Biosciences Holdings.
Annual Free Cash Flow Generation for Harmony Biosciences Holdings (2021–2025)
Year-by-year Free Cash Flow Generation Index for Harmony Biosciences Holdings. Check HRMY total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $347.89 Million | $348.20 Million | $310.00K | ▲ +0.4% |
| 2024 | 0.99x | $218.67 Million | $219.82 Million | $1.15 Million | ▼ -0.4% |
| 2023 | 1.00x | $219.07 Million | $219.39 Million | $312.00K | ▼ 0.0% |
| 2022 | 1.00x | $144.29 Million | $144.47 Million | $172.00K | ▲ +0.2% |
| 2021 | 1.00x | $98.26 Million | $98.56 Million | $298.00K | — |